Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients
- Status
- SUSPENDED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
- Status
- COMPLETED
- Phase
- N/A
Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Immunotherapy of Stage III/IV Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy of Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Pain Relief - Tramadol Versus Ibuprofen
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2